XML 49 R30.htm IDEA: XBRL DOCUMENT v3.24.4
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2024
Stock-Based Compensation [Abstract]  
Schedule of Stock-Based Compensation Expense During the years ended September 30, 2024 and 2023, stock-based expense related to the stock options and restricted stock units was included in selling, general and administrative and research and development costs as follows in the accompanying statements of operations:
   2024   2023 
Selling, general and administrative  $1,064,819   $905,108 
Research and development   279,657    200,349 
Total stock-based compensation expense  $1,344,476   $1,105,457 
Schedule of Stock Option Plan Activity The following table summarizes the Company’s stock option plan activity for the years ended September 30, 2024 and 2023 as follows:
   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Term (years)
   Aggregate
Intrinsic
Value(1)
 
Outstanding at September 30, 2022   1,239,915   $5.40    8.0   $89,295 
Granted   469,512   $1.55         
Exercised   
   $
         
Forfeited/Cancelled   (1,000)  $3.78         
Outstanding at September 30, 2023   1,708,427   $4.34    7.7   $20,064 
Granted   1,225,669   $1.26         
Exercised   
   $
         
Forfeited/Cancelled   (120,000)  $1.33         
Outstanding at September 30, 2024   2,814,096   $3.13    7.7   $22,685 
Vested and expected to vest at September 30, 2024   2,814,096   $3.13    7.7   $22,685 
Vested and exercisable at September 30, 2024   1,409,840   $4.79    6.4   $22,643 
Schedule of Weighted Average Assumptions The weighted-average assumptions used in the Black-Scholes option-pricing model are as follows for the stock options granted during the years ended September 30:
   2024   2023 
Expected stock price volatility   111.9%   57.4%
Expected life of options (years)   6.1    5.8 
Expected dividend yield   0%   0%
Risk free interest rate   4.6%   3.7%
Schedule of Summary of Restricted Stock Unit A summary of restricted stock unit (“RSU”) activity is as follows for the years ended September 30, 2024 and 2023:
   Number of 
   Shares 
Non-vested at September 30, 2022   414,430 
Granted   310,728 
Vested   (331,788)
Non-vested at September 30, 2023   393,370 
Granted   1,006,725 
Vested   (270,333)
Non-vested at September 30, 2024   1,129,762